Healthcare Infection Control Practices Advisory Committee (HICPAC); Correction, 39852-39853 [2023-12990]

Download as PDF 39852 Federal Register / Vol. 88, No. 117 / Tuesday, June 20, 2023 / Notices on FedRAMP through a series of presentations and facilitated discussions reviewing current state and examining top priorities for the secure adoption of cloud computing technologies in the federal government as well as a vote on the Committee’s first course of action. The meeting agenda will be posted on https://gsa.gov/fscac prior to the meeting. Meeting Attendance This meeting is open to the public and can be attended virtually. Meeting registration and information is available at https://gsa.gov/fscac. Registration for attending the meeting is highly encouraged by 5:00 p.m. on Monday, July 17, 2023 to obtain the virtual meeting information. After registration, individuals will receive meeting attendance information via email. For information on services for individuals with disabilities, or to request accommodation for a disability, please email the FSCAC staff at FSCAC@gsa.gov at least 10 days prior to the meeting. Live captioning may be provided virtually. Public Comment Members of the public will have the opportunity to provide oral public comment during the FSCAC meeting by indicating their preference when registering. Written public comments can be submitted at any time by completing the public comment form on our website, https://gsa.gov/fscac. All written public comments received prior to Wednesday, July 12, 2023, will be provided to FSCAC members in advance of the meeting. Elizabeth Blake, Senior Advisor, Federal Acquisition Service, General Services Administration. [FR Doc. 2023–13031 Filed 6–16–23; 8:45 am] BILLING CODE P GOVERNMENT ACCOUNTABILITY OFFICE Request for Health Information Technology Advisory Committee (HITAC) Nominations Government Accountability Office (GAO). ACTION: Request for letters of nomination and resumes. lotter on DSK11XQN23PROD with NOTICES1 AGENCY: implementation of a health information technology infrastructure that advances the electronic access, exchange, and use of health information. The Act gave the Comptroller General of the United States responsibility for appointing a portion of HITAC’s members. The Act requires that members at least reflect providers, ancillary health care workers, consumers, purchasers, health plans, health information technology developers, researchers, patients, relevant Federal agencies, and individuals with technical expertise on health care quality, system functions, privacy, security, and on the electronic exchange and use of health information, including the use standards for such activity. GAO is now accepting nominations for HITAC appointments that will be effective January 1, 2024. Members serve 3-year terms, with the terms subject to renewal, for a total not to exceed 6 years of service on the committee. From these nominations, GAO expects to appoint two to three new HITAC members, focusing especially on patients or consumers, health plans or purchasers, and researchers. Nominations should be sent to the email address listed below. Letters of nomination and resumes should be submitted no later than July 31, 2023, to ensure adequate opportunity for review and consideration of nominees prior to appointment. DATES: Submit letters of nomination and resumes to HITCommittee@gao.gov. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Shannon Legeer at (202) 512–3197 or legeers@gao.gov if you do not receive an acknowledgment within a week of submission or if you need additional information. For general information, contact GAO’s Office of Public Affairs, (202) 512–4800. Authority: Sec. 4003(e), Pub. L. 114– 255, 130 Stat. 1168 (42 U.S.C. 300jj–12). Gene L. Dodaro, Comptroller General of the United States. [FR Doc. 2023–12970 Filed 6–16–23; 8:45 am] BILLING CODE 1610–02–P The 21st Century Cures Act established HITAC to provide recommendations to the National Coordinator for Health Information Technology on policies, standards, implementation specifications, and certification criteria relating to the SUMMARY: VerDate Sep<11>2014 16:52 Jun 16, 2023 Jkt 259001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC); Correction Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). This is a virtual meeting. The public is welcomed to listen to the meeting via Zoom; 500 teleconference lines are available. Time will be available for public comment. Registration is required. SUMMARY: FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, l600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329. Telephone (404) 718–8039; Email: hicpac@cdc.gov. SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC); June 8, 2023, 9:00 a.m. to 5:00 p.m., EDT, and June 9, 2023, 9:00 a.m. to 12:00 p.m., EDT in the original FRN. The virtual meeting was published in the Federal Register on May 1, 2023, Volume 88, Number 83, page/s/26547– 26548. The virtual meeting is being corrected to revise the SUMMARY, ADDRESSES, and SUPPLEMENTARY INFORMATION and should read as follows: In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). This meeting will be virtual for all public attendees, limited only by audio and web conference lines (500 audio and web conference lines are available). Registration is required. To register for this web conference, please go to: www.cdc.gov/hicpac. All registered participants will receive the meeting link and instructions shortly before the meeting. SUMMARY: E:\FR\FM\20JNN1.SGM 20JNN1 Federal Register / Vol. 88, No. 117 / Tuesday, June 20, 2023 / Notices Registration is required. All registered participants will receive instructions shortly before the meeting. Please click first link for day one and the second link for day two to join the webinar: https://cdc.zoomgov.com/j/1616828 862?pwd=N3hmSTEvQjQ3ZHFScVM yM1k2Mk8yUT09. Meeting ID: 161 682 8862. Passcode: 74249065. https://cdc.zoomgov.com/j/161494 4394?pwd=UWdBRDNNK2pDdS9PMjl MZzYvRVFzZz09. Meeting ID: 161 494 4394. Passcode: 26658671. ADDRESSES: SUPPLEMENTARY INFORMATION: Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion (DHQP), the Director, National Center for Emerging and Zoonotic Infectious Diseases, the Director, CDC, and the Secretary, Department of Health and Human Services, regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters to be Considered: The agenda will include updates on CDC’s activities for prevention of healthcare-associated infections. It will also include updates from the following HICPAC workgroups: the Isolation Precautions Guideline workgroup, the Dental Unit Waterline Guideline Workgroup, the Healthcare Personnel Guideline Workgroup, and the National Healthcare Safety Network Workgroup. The agenda also includes updates on CDC and DHQP activities. Agenda items are subject to change as priorities dictate. lotter on DSK11XQN23PROD with NOTICES1 Public Participation Oral Public Comment: Time will be available for public comment. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Please note that the public comment period may end before the time indicated, following the last call for comments. Written Public Comment: The public is welcomed to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed above. The deadline for receipt of written public comment was May 26, VerDate Sep<11>2014 16:52 Jun 16, 2023 Jkt 259001 2023. All requests must contain the name, address, and organizational affiliation of the speaker, as well as the topic being addressed. Written comments should not exceed one singlespaced typed page in length and delivered in 3 minutes or less. Written comments received in advance of the meeting will be included in the official record of the meeting. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 39853 Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. process which included the publication of 60- and 30-day Federal Register notices. The scope of the April 2021 umbrella accounts for Medicaid and CHIP State plan amendments, waivers, demonstrations, and reporting. This Federal Register notice seeks public comment on one or more of our collection of information requests that we believe are generic and fall within the scope of the umbrella. Interested persons are invited to submit comments regarding our burden estimates or any other aspect of this collection of information, including: the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. [FR Doc. 2023–12990 Filed 6–16–23; 8:45 am] DATES: BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10398 #64] Medicaid and Children’s Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: On May 28, 2010, the Office of Management and Budget (OMB) issued Paperwork Reduction Act (PRA) guidance related to the ‘‘generic’’ clearance process. Generally, this is an expedited process by which agencies may obtain OMB’s approval of collection of information requests that are ‘‘usually voluntary, low-burden, and uncontroversial collections,’’ do not raise any substantive or policy issues, and do not require policy or methodological review. The process requires the submission of an overarching plan that defines the scope of the individual collections that would fall under its umbrella. On October 23, 2011, OMB approved our initial request to use the generic clearance process under control number 0938–1148 (CMS–10398). It was last approved on April 26, 2021, via the standard PRA SUMMARY: PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 Comments must be received by July 5, 2023. ADDRESSES: When commenting, please reference the applicable form number (see below) and the OMB control number (0938–1148). To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: CMS–10398 (#64)/OMB control number: 0938–1148, Room C4– 26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing. FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. Following is a summary of the use and burden associated with the subject information collection(s). More detailed information SUPPLEMENTARY INFORMATION: E:\FR\FM\20JNN1.SGM 20JNN1

Agencies

[Federal Register Volume 88, Number 117 (Tuesday, June 20, 2023)]
[Notices]
[Pages 39852-39853]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-12990]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC); Correction

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC), announces the following meeting 
of the Healthcare Infection Control Practices Advisory Committee 
(HICPAC). This is a virtual meeting. The public is welcomed to listen 
to the meeting via Zoom; 500 teleconference lines are available. Time 
will be available for public comment. Registration is required.

FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, National 
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers 
for Disease Control and Prevention, l600 Clifton Road NE, Mailstop H16-
3, Atlanta, Georgia 30329. Telephone (404) 718-8039; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Healthcare Infection Control Practices Advisory 
Committee (HICPAC); June 8, 2023, 9:00 a.m. to 5:00 p.m., EDT, and June 
9, 2023, 9:00 a.m. to 12:00 p.m., EDT in the original FRN.
    The virtual meeting was published in the Federal Register on May 1, 
2023, Volume 88, Number 83, page/s/26547-26548.
    The virtual meeting is being corrected to revise the SUMMARY, 
ADDRESSES, and SUPPLEMENTARY INFORMATION and should read as follows:

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC), announces the following meeting 
of the Healthcare Infection Control Practices Advisory Committee 
(HICPAC). This meeting will be virtual for all public attendees, 
limited only by audio and web conference lines (500 audio and web 
conference lines are available). Registration is required. To register 
for this web conference, please go to: www.cdc.gov/hicpac. All 
registered participants will receive the meeting link and instructions 
shortly before the meeting.


[[Page 39853]]


ADDRESSES: Registration is required. All registered participants will 
receive instructions shortly before the meeting. Please click first 
link for day one and the second link for day two to join the webinar:
    https://cdc.zoomgov.com/j/1616828862?pwd=N3hmSTEvQjQ3ZHFScVMyM1k2Mk8yUT09.
    Meeting ID: 161 682 8862.
    Passcode: 74249065.
    https://cdc.zoomgov.com/j/1614944394?pwd=UWdBRDNNK2pDdS9PMjlMZzYvRVFzZz09.
    Meeting ID: 161 494 4394.
    Passcode: 26658671.

SUPPLEMENTARY INFORMATION:
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases, the Director, CDC, and the Secretary, Department 
of Health and Human Services, regarding (1) the practice of healthcare 
infection prevention and control; (2) strategies for surveillance, 
prevention, and control of infections, antimicrobial resistance, and 
related events in settings where healthcare is provided; and (3) 
periodic updating of CDC guidelines and other policy statements 
regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters to be Considered: The agenda will include updates on CDC's 
activities for prevention of healthcare-associated infections. It will 
also include updates from the following HICPAC workgroups: the 
Isolation Precautions Guideline workgroup, the Dental Unit Waterline 
Guideline Workgroup, the Healthcare Personnel Guideline Workgroup, and 
the National Healthcare Safety Network Workgroup. The agenda also 
includes updates on CDC and DHQP activities. Agenda items are subject 
to change as priorities dictate.

Public Participation

    Oral Public Comment: Time will be available for public comment. 
Members of the public who wish to provide public comments should plan 
to attend the public comment session at the start time listed. Please 
note that the public comment period may end before the time indicated, 
following the last call for comments.
    Written Public Comment: The public is welcomed to submit written 
comments in advance of the meeting. Comments should be submitted in 
writing by email to the contact person listed above. The deadline for 
receipt of written public comment was May 26, 2023. All requests must 
contain the name, address, and organizational affiliation of the 
speaker, as well as the topic being addressed. Written comments should 
not exceed one single-spaced typed page in length and delivered in 3 
minutes or less. Written comments received in advance of the meeting 
will be included in the official record of the meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-12990 Filed 6-16-23; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.